![[CME 3] Managing Adverse Events with Psychopharmacology](https://psychiatryeducationforum.com/wp-content/uploads/2020/11/Untitled-design-2.png)
CME ACADEMY #3
COMPREHENSIVE APPROACHES FOR MANAGING ADVERSE EVENTS WITH PSYCHOPHARMACOLOGY
TOTAL CREDITS: 6.75 AMA PRA CATEGORY 1 CREDITS
ENROLLEMENT CLOSed
LEARNING OBJECTIVES:
By the end of this course, participants should be able to:
- Identify and manage common adverse effects associated with antipsychotics, Mood Stabilizers and Antidepressants.
- Develop targeted treatment plans for specific adverse events of antipsychotics like Clozapine and Mood Stabilizers like Lithium.
- Evaluate the comparative efficacy of VMAT-2 inhibitors for tardive dyskinesia management to optimize patient outcomes.
- Assess the relationship between antipsychotic use and breast cancer risk to guide safer long-term treatment planning.
- Recognize and address antidepressant-induced adverse effects, such as bruxism, excessive sweating, and other condition-specific risks, to improve patient comfort and adherence to treatment.
Course Instructor
TABLE OF CONTENT:
[Antipsychotics]: Managing Adverse Events
[Mood Stabilizers]: Managing Adverse Events
[Antidepressants]: Managing Adverse Events
Earn CME Credits
Note: This CME Activity has expired on Oct 26, 2025
Accreditation and Designation Statements and Disclosure Report:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and the Psychiatry Education Forum.
PeerPoint Medical Education Institute designates the live format for this educational activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- Enduring activity date: October 26, 2024 – October 26, 2025
Financial Disclosures:
- All presenters, planners, editors, or staff report no relationships to disclose: “I do not have at present nor have had within the last 24 months, any financial relationships with ineligible companies.”
